San Francisco Veterans Affairs Medical Center and Department of Medicine, University of California at San Francisco & Endocrine Unit (111N2), San Francisco, CA 94121, USA.
Oncogene. 2012 Jan 12;31(2):149-60. doi: 10.1038/onc.2011.222. Epub 2011 Jun 20.
MicroRNAs are often associated with the pathogenesis of many cancers, including head and neck squamous cell carcinoma (HNSCC). In particular, microRNA-21 (miR-21) appears to have a critical role in tumor cell survival, chemoresistance and HNSCC progression. In this study, we investigated matrix hyaluronan (HA)-induced CD44 (a primary HA receptor) interaction with the stem cell markers, Nanog and Stat-3, in HNSCC cells (HSC-3 cells). Our results indicate that HA binding to CD44 promotes Nanog-Stat-3 (also tyrosine phosphorylated Stat-3) complex formation, nuclear translocation and transcriptional activation. Further analyses reveal that miR-21 is controlled by an upstream promoter containing Stat-3 binding site(s), while chromatin immunoprecipitation assays demonstrate that stimulation of miR-21 expression by HA/CD44 signaling is Nanog/Stat-3-dependent in HNSCC cells. This process results in a decrease of a tumor suppressor protein (PDCD4), and an upregulation of i nhibitors of the apoptosis family of proteins (IAPs) as well as chemoresistance in HSC-3 cells. Treatment of HSC-3 cells with Nanog- and/or Stat-3-specific small interfering RNAs effectively blocks HA-mediated Nanog-Stat-3 signaling events, abrogates miR-21 production and increases PDCD4 expression. Subsequently, this Nanog-Stat-3 signaling inhibition causes downregulation of survival protein (IAP) expression and enhancement of chemosensitivity. To further evaluate the role of miR-21 in tumor cell-specific functions, HSC-3 cells were also transfected with a specific anti-miR-21 inhibitor in order to silence miR-21 expression and block its target functions. Our results demonstrate that anti-miR-21 inhibitor not only upregulates PDCD4 expression but also decreases IAP expression and enhances chemosensitivity in HA-treated HNSCC cells. Together, these findings indicate that the HA-induced CD44 interaction with Nanog and Stat-3 has a pivotal role in miR-21 production leading to PDCD4 reduction, IAP upregulation and chemoresistance in HNSCC cells. This novel Nanog/Stat-3 signaling pathway-specific mechanism involved in miR-21 production is significant for the formation of future intervention strategies in the treatment of HA/CD44-activated HNSCC.
微小 RNA 通常与许多癌症的发病机制有关,包括头颈部鳞状细胞癌 (HNSCC)。特别是 microRNA-21 (miR-21) 似乎在肿瘤细胞存活、化疗耐药和 HNSCC 进展中发挥关键作用。在这项研究中,我们研究了基质透明质酸 (HA)-诱导的 CD44(主要的 HA 受体)与 HNSCC 细胞 (HSC-3 细胞)中的干细胞标记物 Nanog 和 Stat-3 的相互作用。我们的结果表明,HA 与 CD44 的结合促进了 Nanog-Stat-3(也为酪氨酸磷酸化 Stat-3)复合物的形成、核转位和转录激活。进一步分析表明,miR-21 受含有 Stat-3 结合位点的上游启动子控制,而染色质免疫沉淀分析表明,HA/CD44 信号刺激 miR-21 表达依赖于 HNSCC 细胞中的 Nanog/Stat-3。这个过程导致肿瘤抑制蛋白 (PDCD4) 的减少,凋亡家族蛋白抑制剂 (IAPs) 的上调以及 HSC-3 细胞的化疗耐药性增加。用 Nanog 和/或 Stat-3 特异性小干扰 RNA 处理 HSC-3 细胞可有效阻断 HA 介导的 Nanog-Stat-3 信号事件,阻断 miR-21 的产生并增加 PDCD4 的表达。随后,这种 Nanog-Stat-3 信号抑制导致存活蛋白 (IAP) 表达的下调和化疗敏感性的增强。为了进一步评估 miR-21 在肿瘤细胞特异性功能中的作用,还将特定的抗 miR-21 抑制剂转染到 HSC-3 细胞中,以沉默 miR-21 的表达并阻断其靶功能。我们的结果表明,抗 miR-21 抑制剂不仅上调 PDCD4 的表达,还降低 HA 处理的 HNSCC 细胞中 IAP 的表达并增强化疗敏感性。总之,这些发现表明,HA 诱导的 CD44 与 Nanog 和 Stat-3 的相互作用在 miR-21 的产生中起着关键作用,导致 PDCD4 的减少、IAP 的上调和 HNSCC 细胞的化疗耐药性。这种涉及 miR-21 产生的新型 Nanog/Stat-3 信号通路特异性机制对头颈部鳞状细胞癌中 HA/CD44 激活的治疗策略的形成具有重要意义。